BlueRock Therapeutics, created in 2016 (Canada), from 2081 sister brands and 17477 competing brands. The BlueRock Therapeutics brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. The sector of BlueRock Therapeutics is Drug Manufacturers.

BlueRock Therapeutics is a brand of BAYER (BAYN) Share price

Share price and profitability of the share BAYER (BlueRock Therapeutics)

Buy BAYER share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 28.56

Portfolio valuation
BAYER (BlueRock Therapeutics) over 5 years* EUR 14.04

Stock market history BAYER (BlueRock Therapeutics)